Christina Szalinski

Christina Szalinski

Christina is a science writer for the American Society for Cell Biology. She earned her Ph.D. in Cell Biology and Molecular Physiology at the University of Pittsburgh.

It may sound like a spam subject line but you can change the trajectory of your career in a few short weeks. If it sounds too good to be true, consider one of the numerous short-term courses, internships, and fellowships in outside-the-lab science careers that can give you a look at a whole new career track.

In the "big data" realms of genome sequencing, there are many surprises left to be untangled. A new bioinformatics paper published January 10 in Nature Chemical Biology unwinds one—a new class of RNA-catalysts.

Modeling membranes, nano-magnets to control cell activity, and a gain-of-function protein behind a severe progressive brainstem disorder were hot topics at the 2013 ASCB Annual Meeting in New Orleans, December 14-18. This year, ASCB continued the tradition of weaving two scientific threads—biophysics and medicine—through many of the 254 science presentations.

Contending that no enemy could have devised a system so effective at destroying U.S. science and technology competitiveness as the policies pursued by Congress and state legislatures in "disinvesting" in education and innovation, a former president of Lockheed Martin and longtime presidential science advisor Norman Augustine warned that the U.S. economic engine was in decline in a recent TEDx talk.

Mathieu Coppey imagines using tiny magnets to move cells within living organisms. Coppey, a researcher at the Institut Curie in Paris, isn't envisioning a modern day version of "magnet therapy" touted a century ago by quack medical practitioners. Instead Coppey is using nanoparticle-size magnets to manipulate processes in cells.

Aside from Google Hangouts and Skype, it was the first time I'd been on video since my friend caught me singing to Spice Girls several years ago. I'd picked a high pressure venue for my return to video—the ASCB Annual Meeting in New Orleans. I was scheduled to give a short talk on Monday about scientists and social media. On Sunday though, I found myself in a small room in the convention center for a previously unscheduled coaching session on video with Susan Tomai, founder of Oratorio, a DC-based company offering media and presentation training.

Thursday, 19 December 2013 11:13

ASCB 2013 Twitter Highlights

Here's what happened at the 2013 ASCB Annual Meeting as told by Twitter users:
Wednesday, 18 December 2013 13:58

Twitter Reactions to ASCB 2013

Here's what people said on Twitter about the 2013 ASCB meeting in New Orleans:

Is there life after graduate school? For doctoral students and postdocs who've been wondering what their future lab life could be like outside academia, say in the biotech industry, here's a chance to get a taste and some intensive training in a free-to-the-student 12-day MBA-style, case-based course. ASCB and the Keck Graduate Institute (KGI), with generous funding from EMD Millipore, have teamed up to offer "Managing Science in the Biotech Industry: An Intensive Course for Students and Postdocs" to 40 postdocs and graduate ASCB members this June in Claremont, CA.

Elaine Fuchs grew up surrounded by scientists. Her father and aunt were scientists at Argonne National Laboratories, and later her older sister became a neuroscientist. So Fuchs has followed in the family footsteps. Today she is a Howard Hughes Medical Institute investigator, a professor at the Rockefeller University, and a widely recognized pioneer in adult stem cell research. She is also a former ASCB President. As an ASCB stalwart and a stem cell pathfinder, Fuchs was drafted to serve on the ASCB Stem Cell Task Force last spring and helped write the preliminary report, which was presented for public comment last month.

Page 2 of 6

Activation Energy Blog